Cargando…

Bioequivalence and Pharmacokinetic Profiles of Generic and Branded Obeticholic Acid in Healthy Chinese Subjects Under Fasting and Fed Conditions

OBJECTIVES: This study was conducted to evaluate the bioequivalence (BE) of a generic form of obeticholic acid (OCA) and Ocaliva(TM) under fasting and fed conditions and to determine the effects of food on the pharmacokinetic (PK) profiles of OCA in healthy Chinese subjects. METHODS: A randomized, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Meng-Na, Yu, Hai-Tao, Li, Ya-Qian, Zeng, Yun, Yang, Shuang, Yang, Guo-Ping, Pei, Qi, Huang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813459/
https://www.ncbi.nlm.nih.gov/pubmed/33469270
http://dx.doi.org/10.2147/DDDT.S289016
_version_ 1783637852382298112
author Wang, Meng-Na
Yu, Hai-Tao
Li, Ya-Qian
Zeng, Yun
Yang, Shuang
Yang, Guo-Ping
Pei, Qi
Huang, Jie
author_facet Wang, Meng-Na
Yu, Hai-Tao
Li, Ya-Qian
Zeng, Yun
Yang, Shuang
Yang, Guo-Ping
Pei, Qi
Huang, Jie
author_sort Wang, Meng-Na
collection PubMed
description OBJECTIVES: This study was conducted to evaluate the bioequivalence (BE) of a generic form of obeticholic acid (OCA) and Ocaliva(TM) under fasting and fed conditions and to determine the effects of food on the pharmacokinetic (PK) profiles of OCA in healthy Chinese subjects. METHODS: A randomized, single-dose, three-sequence, three-period, partial replicated crossover study was conducted with a 21-day washout interval between periods under fasting (n=48) and fed (n=48) conditions. Blood samples for OCA and its metabolites Glyco-OCA and Tauro-OCA were collected up to 168 hours after administration in each period. PK parameters were calculated using the non-compartmental method. Geometric mean ratios for PK parameters of the test to reference drug under fasting and fed conditions and their 90% confidence intervals were estimated. Safety evaluations were carried out all through the study. RESULTS: A total of 91 subjects completed the study with 45 in a fasted state and 46 receiving a high-fat diet. There were no serious or unexpected drug-related adverse events occurring during the study. There was no significant difference in the main PK parameters of the two preparations, irrespective of the fasting or fed conditions. Under fasting and fed conditions, the S(WR) of lnC(max), lnAUC(0-t) and lnAUC(0-∞) were 0.445, 0.370, 0.448, 0.340, 0.168, and 0.180, respectively. Thus, the average BE or the reference-scaled average BE was used to verify that the two preparations were bioequivalent under fasting and fed conditions. Compared with the fasting state, the AUC(0-t) of the test drug, the AUC(0-t), and AUC(0-∞) of the reference drug were higher in the fed state. CONCLUSION: The test drug and the reference drug were BE and well tolerated in Chinese healthy subjects under both fasting and fed conditions. Food-intake may cause a significant difference in the main PK parameters of the two preparations.
format Online
Article
Text
id pubmed-7813459
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78134592021-01-18 Bioequivalence and Pharmacokinetic Profiles of Generic and Branded Obeticholic Acid in Healthy Chinese Subjects Under Fasting and Fed Conditions Wang, Meng-Na Yu, Hai-Tao Li, Ya-Qian Zeng, Yun Yang, Shuang Yang, Guo-Ping Pei, Qi Huang, Jie Drug Des Devel Ther Original Research OBJECTIVES: This study was conducted to evaluate the bioequivalence (BE) of a generic form of obeticholic acid (OCA) and Ocaliva(TM) under fasting and fed conditions and to determine the effects of food on the pharmacokinetic (PK) profiles of OCA in healthy Chinese subjects. METHODS: A randomized, single-dose, three-sequence, three-period, partial replicated crossover study was conducted with a 21-day washout interval between periods under fasting (n=48) and fed (n=48) conditions. Blood samples for OCA and its metabolites Glyco-OCA and Tauro-OCA were collected up to 168 hours after administration in each period. PK parameters were calculated using the non-compartmental method. Geometric mean ratios for PK parameters of the test to reference drug under fasting and fed conditions and their 90% confidence intervals were estimated. Safety evaluations were carried out all through the study. RESULTS: A total of 91 subjects completed the study with 45 in a fasted state and 46 receiving a high-fat diet. There were no serious or unexpected drug-related adverse events occurring during the study. There was no significant difference in the main PK parameters of the two preparations, irrespective of the fasting or fed conditions. Under fasting and fed conditions, the S(WR) of lnC(max), lnAUC(0-t) and lnAUC(0-∞) were 0.445, 0.370, 0.448, 0.340, 0.168, and 0.180, respectively. Thus, the average BE or the reference-scaled average BE was used to verify that the two preparations were bioequivalent under fasting and fed conditions. Compared with the fasting state, the AUC(0-t) of the test drug, the AUC(0-t), and AUC(0-∞) of the reference drug were higher in the fed state. CONCLUSION: The test drug and the reference drug were BE and well tolerated in Chinese healthy subjects under both fasting and fed conditions. Food-intake may cause a significant difference in the main PK parameters of the two preparations. Dove 2021-01-14 /pmc/articles/PMC7813459/ /pubmed/33469270 http://dx.doi.org/10.2147/DDDT.S289016 Text en © 2021 Wang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wang, Meng-Na
Yu, Hai-Tao
Li, Ya-Qian
Zeng, Yun
Yang, Shuang
Yang, Guo-Ping
Pei, Qi
Huang, Jie
Bioequivalence and Pharmacokinetic Profiles of Generic and Branded Obeticholic Acid in Healthy Chinese Subjects Under Fasting and Fed Conditions
title Bioequivalence and Pharmacokinetic Profiles of Generic and Branded Obeticholic Acid in Healthy Chinese Subjects Under Fasting and Fed Conditions
title_full Bioequivalence and Pharmacokinetic Profiles of Generic and Branded Obeticholic Acid in Healthy Chinese Subjects Under Fasting and Fed Conditions
title_fullStr Bioequivalence and Pharmacokinetic Profiles of Generic and Branded Obeticholic Acid in Healthy Chinese Subjects Under Fasting and Fed Conditions
title_full_unstemmed Bioequivalence and Pharmacokinetic Profiles of Generic and Branded Obeticholic Acid in Healthy Chinese Subjects Under Fasting and Fed Conditions
title_short Bioequivalence and Pharmacokinetic Profiles of Generic and Branded Obeticholic Acid in Healthy Chinese Subjects Under Fasting and Fed Conditions
title_sort bioequivalence and pharmacokinetic profiles of generic and branded obeticholic acid in healthy chinese subjects under fasting and fed conditions
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813459/
https://www.ncbi.nlm.nih.gov/pubmed/33469270
http://dx.doi.org/10.2147/DDDT.S289016
work_keys_str_mv AT wangmengna bioequivalenceandpharmacokineticprofilesofgenericandbrandedobeticholicacidinhealthychinesesubjectsunderfastingandfedconditions
AT yuhaitao bioequivalenceandpharmacokineticprofilesofgenericandbrandedobeticholicacidinhealthychinesesubjectsunderfastingandfedconditions
AT liyaqian bioequivalenceandpharmacokineticprofilesofgenericandbrandedobeticholicacidinhealthychinesesubjectsunderfastingandfedconditions
AT zengyun bioequivalenceandpharmacokineticprofilesofgenericandbrandedobeticholicacidinhealthychinesesubjectsunderfastingandfedconditions
AT yangshuang bioequivalenceandpharmacokineticprofilesofgenericandbrandedobeticholicacidinhealthychinesesubjectsunderfastingandfedconditions
AT yangguoping bioequivalenceandpharmacokineticprofilesofgenericandbrandedobeticholicacidinhealthychinesesubjectsunderfastingandfedconditions
AT peiqi bioequivalenceandpharmacokineticprofilesofgenericandbrandedobeticholicacidinhealthychinesesubjectsunderfastingandfedconditions
AT huangjie bioequivalenceandpharmacokineticprofilesofgenericandbrandedobeticholicacidinhealthychinesesubjectsunderfastingandfedconditions